Vitamin Patch Maker Barrière Strikes Walmart Deal, Projects Doubling Revenue by 2026
Vitamin patch company Barrière told CNBC exclusively it is on track to double revenue this year to $10 million. The projection follows a major retail expansion with Walmart and the launch of the first supplement patch for lactose intolerance. A 6:20 video segment details the company's push into the supplement market.
CnbcVitamin patch brand Barrière is on track to double its revenue in 2026, projecting $10 million total revenue that year, the company told CNBC exclusively. The projection comes as Barrière landed a 1,700 store deal with Walmart. The retailer agreement forms a central piece of the company's expansion into mainstream retail channels.
Barrière is also rolling out the first ever supplement patch for lactose intolerance. The new product aims to address a common dietary need through transdermal delivery rather than traditional pills or gummies. Cnbc reported that Barrière told the network exclusively about its 2026 revenue projection, Walmart deal and lactose intolerance patch launch.
The disclosures arrived alongside a video segment produced by the outlet. The CNBC video segment on Barrière vitamin patches runs 06:20 in length. It examines how the company is attempting to disrupt the supplement industry while outlining potential challenges in scaling a patch-based delivery system.
Barrière's revenue target for 2026 represents a doubling from its current run rate. Company officials positioned the Walmart partnership and new product introduction as key drivers behind the accelerated growth. The 1,700-store Walmart deal marks a significant increase in Barrière's physical retail footprint.
Patches will now reach consumers across a broad network of locations previously unavailable to the brand. The lactose intolerance patch represents an industry first according to Barrière. Its introduction expands the company's portfolio beyond general vitamins into targeted digestive support.
Cnbc reported the details within the past hour. The segment features commentary on both the innovation potential of vitamin patches and the hurdles the category faces in gaining wider consumer acceptance. Barrière's bet centers on convenience and absorption claims associated with patches over swallowed supplements.
The company has not released specific prior-year revenue figures beyond confirming the projected doubling.
Key Facts
Story Timeline
3 events- 2026-05-07
CNBC publishes 06:20 video segment and reports Barrière's exclusive statements on revenue, Walmart deal and lactose intolerance patch
1 sourceCNBC - 2026
Barrière projects $10 million total revenue, doubling prior run rate
1 sourceBarrière via CNBC - 2026
Barrière lands 1,700 store Walmart deal and rolls out first lactose intolerance supplement patch
1 sourceBarrière via CNBC
Potential Impact
- 01
Introduction of targeted lactose intolerance patch may open new subcategory within digestive health supplements.
- 02
Expanded retail access through Walmart could accelerate consumer adoption of patch-format supplements.
- 03
Doubling of revenue to $10 million would validate transdermal delivery model in competitive supplement market.
Transparency Panel
Related Stories
Financial TimesRomania Expels Russian Consul General After Drone Strike
Romania ordered the expulsion of Russia's Consul General in Constanta and closed the consulate after a drone struck an apartment building in Galati, injuring two people. NATO and Romanian officials condemned the incident as reckless escalation.
fortune.comHouse Republicans stall on immigration enforcement funding bill
A roughly $70 billion measure to fund immigration enforcement through the end of President Donald Trump's term stalled in the House. Progress halted over White House ballroom security funding and a proposed $1.8 billion fund for government-mistreatment claims.
techjuice.pkCanada Seeks 50 Percent Rise in Exports to China by 2030
Foreign Minister Anita Anand stated the export target during a visit by her Chinese counterpart to Ottawa. The announcement comes amid U.S. tariffs that have altered trade patterns.